BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
McKesson
Express Scripts
Deloitte
Covington
Queensland Health
Teva
UBS
Chubb

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077443

« Back to Dashboard

NDA 077443 describes ATENOLOL, which is a drug marketed by Able, Alvogen Malta, Apothecon, Aurobindo Pharma, Dava Pharms Inc, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, Sandoz, SCS, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Unique Pharm Labs, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, and Mutual Pharm, and is included in forty-one NDAs. It is available from fifty-nine suppliers. Additional details are available on the ATENOLOL profile page.

The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Summary for 077443
Tradename:ATENOLOL
Applicant:Unique Pharm Labs
Ingredient:atenolol
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 077443
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 077443
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATENOLOL atenolol TABLET;ORAL 077443 ANDA Blenheim Pharmacal, Inc. 10544-167 10544-167-30 30 TABLET in 1 BOTTLE (10544-167-30)
ATENOLOL atenolol TABLET;ORAL 077443 ANDA Blenheim Pharmacal, Inc. 10544-167 10544-167-90 90 TABLET in 1 BOTTLE (10544-167-90)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Sep 13, 2006TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Sep 13, 2006TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Sep 13, 2006TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Chubb
Moodys
Deloitte
Julphar
Argus Health
Chinese Patent Office
Boehringer Ingelheim
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot